Filing Details
- Accession Number:
- 0001127602-14-027199
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-04 16:24:28
- Reporting Period:
- 2014-09-02
- Filing Date:
- 2014-09-04
- Accepted Time:
- 2014-09-04 16:24:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242993 | M Edward Fitzgerald | C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 | Executive Vp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-02 | 25,000 | $5.23 | 305,960 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-02 | 25,000 | $6.22 | 280,960 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-09-02 | 25,000 | $5.23 | 305,960 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-02 | 25,000 | $6.22 | 280,960 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-09-02 | 25,000 | $0.00 | 25,000 | $5.23 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-09-02 | 25,000 | $0.00 | 25,000 | $5.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2006-09-09 | 2014-09-09 | No | 4 | M | Direct |
| 0 | 2006-09-09 | 2014-09-09 | No | 4 | M | Direct |
Footnotes
- Shares were acquired upon the exercise of outstanding stock options at $5.23 per share.
- This sale was pursuant to a 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.14 to $6.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
